Gloria M.
- Country
- Spain
- Department
- Oncology Department
Research Overview
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- Sacituzumab Tirumotecan With or Without Bevacizumab Versus Standard of Care in Patients With Newly Diagnosed Advanced HRD-Negative Ovarian Cancer Following Platinum-Based Chemotherapy
- Phase Ib/II Study of Bexmarilimab Plus Doxorubicin for Safety and Efficacy in Adults with Metastatic Soft‑Tissue Sarcoma
Data & Insights
Has run more than one trial at 84 of 196 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in the treatment of gastrointestinal stromal tumors (GIST), conducting innovative research in combination therapy approaches. Their work explores novel therapeutic strategies for patients with this rare form of gastrointestinal cancer.
- GIST management
- Targeted combination therapies
- Tyrosine kinase inhibitor treatments
Gynecologic Oncology
The investigator focuses on advancing treatment options for locally advanced cervical cancer. Their research encompasses novel therapeutic approaches aimed at improving outcomes for women and young adults affected by this condition.
- Cervical cancer therapeutics
- Advanced-stage disease management
- Progression-free survival studies
Clinical Innovation
The investigator's work centers on evaluating novel therapeutic agents across multiple oncology domains. Their research involves assessing new treatment modalities and their impact on patient outcomes.
- Comparative treatment studies
- Drug efficacy assessment
- Patient response evaluation
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.